Skip to main content

Advertisement

Log in

Adipose-derived stromal vascular fraction injection following core decompression and biochemistry artificial bone graft implantation in osteonecrosis of the femoral head

  • Original Paper
  • Published:
International Orthopaedics Aims and scope Submit manuscript

A Letter to the Editor to this article was published on 11 July 2023

Abstract

Purpose

To determine how adipose-derived stromal vascular fraction (SVF) injection following core decompression (CD) and biochemistry artificial bone graft implantation affects outcomes in patients with osteonecrosis of the femoral head (ONFH).

Methods

A total of 19 patients (28 hips) with stage I-IIIA ONFH received adipose-derived SVF injection and combined core decompression and biochemistry artificial bone graft implantation, followed up for a minimum of two years. Disease progression was evaluated according to the Association Research Circulation Osseous (ARCO) staging system, and the change of the ratio of the necrotic volume to femoral head volume was calculated with MRI before and after operation.

Results

At the last follow-up, 15 hips remained stable, and 13 hips had a progression, according to the ARCO staging system. A total of eight hips (5 with ARCO stage II and 3 with staged IIIA at baseline) progressed to post-collapse stage (stage IIIB-IV). In total, seven of eight hips with post-collapse stage and one with IIIA stage at follow-up converted to THAs in an average of 17.5 months (range, 11–68 months) postoperatively. The mean ratio of the necrotic lesion volume to the femoral head significantly decreased in hips with ARCO stage I (17.9 ± 3.0% to 9.8 ± 1.3%, p = 0.012, Δ necrosis ratio = 8.1 ± 4.2%) and stage II (22.7 ± 6.3% to 17.1 ± 9.4%, p = 0.001, Δ necrosis ratio = 5.7 ± 6.6%) at baseline. For the eight hips that progressed to post-collapse stage, the mean necrosis ratio increased from 27.4 ± 5.4% to 31.1 ± 4.0% (p = 0.146), Δ necrosis ratio =  − 3.7 ± 3.9%. For the other 20 hips radiological survived, the mean necrosis ratio improved from 19.9 ± 4.4% to 11.8 ± 3.3% (p < 0.001), with Δ necrosis ratio = 8.1 ± 4.9%.

Conclusion

Adipose-derived SVF injection following core decompression and biochemistry artificial bone graft implantation is safe and could effectively repair the necrosis lesion and delay disease progression in patients with early-stage ONFH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data availability

The data that support the findings of this study are available upon request from the corresponding author.

Code availability

Not applicable.

References

  1. Mont MA, Hungerford DS (1995) Non-traumatic avascular necrosis of the femoral head. J Bone Joint Surg Am 77:459–474. https://doi.org/10.2106/00004623-199503000-00018

    Article  CAS  PubMed  Google Scholar 

  2. Lieberman JR (2004) Core decompression for osteonecrosis of the hip Clin Orthop Relat Res 29–33.  https://doi.org/10.1097/00003086-200401000-00006

  3. Hernigou P, Beaujean F (2002) Treatment of osteonecrosis with autologous bone marrow grafting Clin Orthop Relat Res 14–23.  https://doi.org/10.1097/00003086-200212000-00003

  4. Zuk PA, Zhu M, Mizuno H, Huang J, Futrell JW, Katz AJ, Benhaim P, Lorenz HP, Hedrick MH (2001) Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 7:211–228. https://doi.org/10.1089/107632701300062859

    Article  CAS  PubMed  Google Scholar 

  5. Wyles CC, Houdek MT, Crespo-Diaz RJ, Norambuena GA, Stalboerger PG, Terzic A, Behfar A, Sierra RJ (2015) Adipose-derived mesenchymal stem cells are phenotypically superior for regeneration in the setting of osteonecrosis of the femoral head. Clin Orthop Relat Res 473:3080–3090. https://doi.org/10.1007/s11999-015-4385-8

    Article  PubMed  PubMed Central  Google Scholar 

  6. Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, March KL, Redl H, Rubin JP, Yoshimura K, Gimble JM (2013) Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy 15:641–648. https://doi.org/10.1016/j.jcyt.2013.02.006

    Article  PubMed  PubMed Central  Google Scholar 

  7. Fodor PB, Paulseth SG (2016) Adipose derived stromal cell (ADSC) injections for pain management of osteoarthritis in the human knee joint. Aesthet Surg J 36:229–236. https://doi.org/10.1093/asj/sjv135

    Article  PubMed  Google Scholar 

  8. Yokota N, Yamakawa M, Shirata T, Kimura T, Kaneshima H (2017) Clinical results following intra-articular injection of adipose-derived stromal vascular fraction cells in patients with osteoarthritis of the knee. Regen Ther 6:108–112. https://doi.org/10.1016/j.reth.2017.04.002

    Article  PubMed  PubMed Central  Google Scholar 

  9. Yokota N, Hattori M, Ohtsuru T, Otsuji M, Lyman S, Shimomura K, Nakamura N (2019) Comparative clinical outcomes after intra-articular injection with adipose-derived cultured stem cells or noncultured stromal vascular fraction for the treatment of knee osteoarthritis. Am J Sports Med 47:2577–2583. https://doi.org/10.1177/0363546519864359

    Article  PubMed  Google Scholar 

  10. Hong Z, Chen J, Zhang S, Zhao C, Bi M, Chen X, Bi Q (2019) Intra-articular injection of autologous adipose-derived stromal vascular fractions for knee osteoarthritis: a double-blind randomized self-controlled trial. Int Orthop 43:1123–1134. https://doi.org/10.1007/s00264-018-4099-0

    Article  PubMed  Google Scholar 

  11. Gangji V, Hauzeur JP, Schoutens A, Hinsenkamp M, Appelboom T, Egrise D (2003) Abnormalities in the replicative capacity of osteoblastic cells in the proximal femur of patients with osteonecrosis of the femoral head. J Rheumatol 30:348–351

    PubMed  Google Scholar 

  12. Hernigou P, Dubory A, Homma Y, Guissou I, FlouzatLachaniette CH, Chevallier N, Rouard H (2018) Cell therapy versus simultaneous contralateral decompression in symptomatic corticosteroid osteonecrosis: a thirty year follow-up prospective randomized study of one hundred and twenty five adult patients. Int Orthop 42:1639–1649. https://doi.org/10.1007/s00264-018-3941-8

    Article  PubMed  Google Scholar 

  13. Hauzeur JP, De Maertelaer V, Baudoux E, Malaise M, Beguin Y, Gangji V (2018) Inefficacy of autologous bone marrow concentrate in stage three osteonecrosis: a randomized controlled double-blind trial. Int Orthop 42:1429–1435. https://doi.org/10.1007/s00264-017-3650-8

    Article  PubMed  Google Scholar 

  14. Riddle DL, Stratford PW (2013) Unilateral vs bilateral symptomatic knee osteoarthritis: associations between pain intensity and function. Rheumatology (Oxford) 52:2229–2237. https://doi.org/10.1093/rheumatology/ket291

    Article  PubMed  Google Scholar 

  15. Yoon PW, Kang JY, Kim CH, Lee SJ, Yoo JJ, Kim HJ, Kang SK, Min JH, Yoon KS (2021) Culture-expanded autologous adipose-derived mesenchymal stem cell treatment for osteonecrosis of the femoral head. Clin Orthop Surg 13:37–46. https://doi.org/10.4055/cios20128

    Article  PubMed  Google Scholar 

  16. Nan K, Zhang Y, Zhang X, Li D, Zhao Y, Jing Z, Liu K, Shang D, Geng Z, Fan L (2021) Exosomes from miRNA-378-modified adipose-derived stem cells prevent glucocorticoid-induced osteonecrosis of the femoral head by enhancing angiogenesis and osteogenesis via targeting miR-378 negatively regulated suppressor of fused (Sufu). Stem Cell Res Ther 12:331. https://doi.org/10.1186/s13287-021-02390-x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Veronesi F, Maglio M, Tschon M, Aldini NN, Fini M (2014) Adipose-derived mesenchymal stem cells for cartilage tissue engineering: state-of-the-art in in vivo studies. J Biomed Mater Res A 102:2448–2466. https://doi.org/10.1002/jbm.a.34896

    Article  CAS  PubMed  Google Scholar 

  18. Wang X, Wang Y, Gou W, Lu Q, Peng J, Lu S (2013) Role of mesenchymal stem cells in bone regeneration and fracture repair: a review. Int Orthop 37:2491–2498. https://doi.org/10.1007/s00264-013-2059-2

    Article  PubMed  PubMed Central  Google Scholar 

  19. Schiavone Panni A, Vasso M, Braile A, Toro G, De Cicco A, Viggiano D, Lepore F (2019) Preliminary results of autologous adipose-derived stem cells in early knee osteoarthritis: identification of a subpopulation with greater response. Int Orthop 43:7–13. https://doi.org/10.1007/s00264-018-4182-6

    Article  PubMed  Google Scholar 

  20. Natali S, Screpis D, Farinelli L, Iacono V, Vacca V, Gigante A, Zorzi C (2021) The use of intra-articular injection of autologous micro-fragmented adipose tissue as pain treatment for ankle osteoarthritis: a prospective not randomized clinical study. Int Orthop 45:2239–2244. https://doi.org/10.1007/s00264-021-05093-3

    Article  PubMed  Google Scholar 

  21. Lin K, Matsubara Y, Masuda Y, Togashi K, Ohno T, Tamura T, Toyoshima Y, Sugimachi K, Toyoda M, Marc H, Douglas A (2008) Characterization of adipose tissue-derived cells isolated with the celution system. Cytotherapy 10:417–426. https://doi.org/10.1080/14653240801982979

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

This study was supported by grants from the Key R&D projects of Zhejiang Province (CN) (2021C03078).

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the study’s conception and design. Material preparation, data collection, and analysis were performed by Zheping Hong and Yin Zhang. The study was designed by Zheping Hong and Qing Bi. The first draft of the manuscript was written by Zheping Hong. Jihang Chen and Qing Bi reviewed and edited the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Qing Bi.

Ethics declarations

Ethical approval

This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Zhejiang Provincial People’s Hospital (2021QT276).

Consent to participate

Informed consent was obtained from all individual participants included in the study.

Consent for publication

Not applicable.

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hong, Z., Zhang, Y., Chen, J. et al. Adipose-derived stromal vascular fraction injection following core decompression and biochemistry artificial bone graft implantation in osteonecrosis of the femoral head. International Orthopaedics (SICOT) 47, 1481–1486 (2023). https://doi.org/10.1007/s00264-023-05792-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00264-023-05792-z

Keywords

Navigation